COVID-19. U07. 1 COVID-19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Admitted patients Laboratory confirmed SARS-COV-2 having PCR or pharyngeal swab positive Both male and female gender Age =18 years. Noninvasive ventilation
Exclusion criteria
Exclusion criteria: Intubated patients Pregnancy Patient inability to tolerate prone positioning Hemodynamically unstable (SBP<90mmhg) or arrhythmias Pressure sores Seizures Recent abdominal surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygen saturation. Timepoint: Outcomes will be measure after each treatment session for 7 consecutive days. Method of measurement: The outcomes will be measured by using pulse oximeter and cardiac monitor.;Respiratory rate. Timepoint: Outcomes will be measure after each treatment session for 7 consecutive days. Method of measurement: The outcomes will be measured by using pulse oximeter and cardiac monitor.;Heart rate. Timepoint: Outcomes will be measure after each treatment session for 7 consecutive days. Method of measurement: The outcomes will be measured by using pulse oximeter and cardiac monitor.;Blood pressure. Timepoint: Outcomes will be measure after each treatment session for 7 consecutive days. Method of measurement: The outcomes will be measured by using pulse oximeter and cardiac monitor. | — |
Countries
Pakistan
Contacts
Khyber Medical University